← Science & SciLifeLab Prize for Young Scientists $30,000 Grand ...Science & SciLifeLab Prize for Young Scientists 2026 | Win ...Computational Biology Awards , Bioinformatics Recognition ...Science & SciLifeLab Prize for Young Scientists 2026 ($30,000 ...Awards and Competitions - About ISCB MODERATE General
Programme Research
Science & SciLifeLab Prize for Young Scientists $30,000 Grand ...Science & SciLifeLab Prize for Young Scientists 2026 | Win ...Computational Biology Awards , Bioinformatics Recognition ...Science & SciLifeLab Prize for Young Scientists 2026 ($30,000 ...Awards and Competitions - About ISCB ·
Programme Site
HIGH confidence Researched 2026-07-10 19:46 · profile: researcher
The Science & SciLifeLab Prize for Young Scientists (AAAS + SciLifeLab/Knut & Alice Wallenberg Foundation, est. 2013) exists to reward the single best piece of recent doctoral research in life sciences, with global visibility as its primary currency: winning essays are published in *Science* magazine, and all four category winners are flown to Stockholm for a ceremony held the same week as the Nobel Prize. The $30,000 grand prize and $10,000 category prizes are secondary to the career-launching publication in one of the world's most-cited journals.
• HARD ELIGIBILITY — PhD must have been conferred between 1 January 2024 and 31 December 2025 (2026 cycle); work described must have been performed during graduate studies • Individual applicant only; essay must clearly delineate the entrant's personal contribution • Research must fall into one of four tracks: Cell & Molecular Biology; Genomics/Proteomics/Systems Biology; Ecology & Environment; Molecular Medicine • No AI-generated text or figures; use of any AI-assisted editing tools must be declared • Past Science Prize winners ineligible within 5 years; AAAS/SciLifeLab employees and relatives ineligible • Submission package: online form + ≤1,000-word essay (1 figure/table permitted, ≤15 refs) + one-page advisor/thesis-committee reference letter + thesis abstract (≤4 double-spaced pages) + publications/awards/experience list • Judging priorities (inferred from past winners and editorial board): novelty and mechanistic depth of the doctoral finding; clarity of writing for a broad scientific audience; societal/translational relevance; quality of the essay as a standalone Science-style piece
Winners consistently come from elite US and European doctoral programmes: 2025 Grand Prize went to Uche Medoh (Molecular Medicine); 2024 Grand Prize to Andrija Sente (Cell & Molecular Biology, European institution); 2023 Grand Prize to Zuzanna Kozicka (Ebert Lab, Harvard Medical School). Category winners include scientists from Caltech, NYU, Scripps/UCSD, ETH-adjacent labs. All winners present a single, clean mechanistic discovery from a completed PhD thesis — not independent post-degree research. The archetype is a mid-to-late PhD student at a research-intensive institution who solved one well-defined biological puzzle with strong methods and clear translational framing.
A scientist who received their PhD between January 2024 and December 2025 from a research-active institution, conducted focused doctoral thesis work within one of the four prize tracks, and can distil that work into a compelling 1,000-word narrative for a broad scientific audience. The ideal applicant has at least one peer-reviewed publication from the thesis work, a supportive thesis advisor willing to write a letter, and a finding with clear mechanistic novelty and societal relevance — not a portfolio of independent projects but a single thesis story told exceptionally well.
Eniola's CCT model (computational neuropharmacology, reward-memory encoding, Bayesian MCMC validation) would map naturally onto the Molecular Medicine track, and her profile is scientifically compelling. However, the programme cannot be applied to: her background, skills, preprints, or independent research would not change the eligibility calculus — the submission itself must be an essay based on completed PhD thesis work, accompanied by a PhD certificate and thesis committee reference letter, and her highest degree is a B.Pharm (2021). If she is admitted to and completes an MSc at MUG/Graz with a strong thesis, she should watch for the 2028 or 2029 cycle (the PhD window shifts annually, so the relevant year will depend on when she receives her doctorate).
FATAL DISQUALIFIER: Eniola does not hold a PhD. The 2026 prize requires a PhD conferred between 1 January 2024 and 31 December 2025, and the required submission package includes a PhD certificate and a thesis abstract — not a preprint or independent research portfolio. Her B.Pharm (2021) and her independent CCT preprints do not satisfy this requirement. No amount of strong framing can override a hard eligibility gate. Additionally: (1) the work described must have been performed *during* graduate studies — her independent 2025–2026 research explicitly falls outside that window; (2) required materials (PhD certificate, thesis committee reference letter, thesis abstract) are structurally impossible to supply; (3) the application portal will reject a non-PhD applicant at the form stage. Do NOT invest time in this application. Redirect effort to pre-PhD-track opportunities (e.g. L'Oréal-UNESCO For Women in Science, NIH Fogarty, TWAS, OWSD, African Academy of Sciences early-career grants, or the DST-NRF/AESA programmes).